Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside. [electronic resource]
Producer: 20130319Description: 123-32 p. digitalISSN:- 1365-2141
- Adaptive Immunity
- Adjuvants, Immunologic -- pharmacology
- Antigens, Neoplasm -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cells, Cultured -- drug effects
- Clinical Trials as Topic
- Dendritic Cells -- immunology
- Diphosphonates -- pharmacology
- Gene Rearrangement, delta-Chain T-Cell Antigen Receptor
- Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor
- Humans
- Immunity, Innate
- Immunologic Surveillance -- immunology
- Immunotherapy, Adoptive
- Killer Cells, Natural -- immunology
- Mesenchymal Stem Cells -- immunology
- Neoplasms -- immunology
- Receptors, Antigen, T-Cell, alpha-beta -- analysis
- Receptors, Antigen, T-Cell, gamma-delta -- analysis
- T-Lymphocyte Subsets -- chemistry
- T-Lymphocytes, Cytotoxic -- chemistry
- T-Lymphocytes, Regulatory -- immunology
- Translational Research, Biomedical
- Tumor Escape -- immunology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.